Dofetilide
Brand name: Dofetilide
Rank #366 of 500 drugs by total cost
$26.7M
Total Cost
98,814
Total Claims
$26.7M
Total Cost
2,518
Prescribers
$271
Cost per Claim
20,361
Beneficiaries
199,414
30-Day Fills
$11K
Avg Cost/Provider
39
Avg Claims/Provider
About Dofetilide
Dofetilide (sold as Dofetilide) was prescribed 98,814 times by 2,518 Medicare Part D providers in 2023, costing the program $26.7M. At $271 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 363 | Solifenacin Succinate (Solifenacin Succinate) | $27.1M | 343,174 |
| 364 | Insulin Aspart (Niacinamide) (Fiasp Flextouch) | $27.0M | 24,598 |
| 365 | Lisinopril/Hydrochlorothiazide (Lisinopril-Hydrochlorothiazide) | $26.8M | 2,304,445 |
| 366 | Dofetilide (Dofetilide) | $26.7M | 98,814 |
| 367 | Plecanatide (Trulance) | $26.6M | 36,026 |
| 368 | Ursodiol (Ursodiol) | $26.6M | 123,719 |
| 369 | Glycerol Phenylbutyrate (Ravicti) | $26.6M | 268 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology